Add a new organization to ROR: NPO ASrid

[ror-curator-bot]

Summary of request: Add a new organization to ROR

Name of organization: ASridEnglish Website: https://asrid.org Link to publications: https://www.jstage.jst.go.jp/article/toxpt/47.1/0/47.1_W7-5/_article/-char/en Organization type: Nonprofit (A non-profit and non-governmental organization involved in conducting or funding research) Wikipedia page: Wikidata ID: ISNI ID: GRID ID: Crossref Funder ID: Aliases: NPO ASridEnglish; 特定非営利活動法人アスリッドJapanese; 特定非営利活動法人 ASridJapanese Labels: 人アスリッド*Japanese Acronym/abbreviation: Related organizations: City: Tokyo Country: Japan Geonames ID: 1850147 Year established: 2014 How will a ROR ID for this organization be used? To identify affiliations for research publications, To be integrated in a scholarly publishing system

Other information about this request: Allow me to provide some additional information about ASrid. ASrid, a non-profit organization to which the authors belong, is an intermediary organization aimed at research, awareness, and support for NANBYO (rare and intractable diseases) in Japan and the Asian region. ASrid was founded in 2014 and committed to providing valuable services/systems for connecting and creating multiple stakeholders related to its field including patients, researchers, medical professionals, companies, and governments. ASrid has established an ethics review committee, we conduct a lot of research on rare and intractable disease areas. We also maintain a website in English where you can find more information about ASrid. 
Our website features a News page where you can explore our past conference presentations and other activities
 (ASrid WEB) https://asrid.org/en 


ASrid has published various research results at both Japanese and international conferences and journals, contributing significantly to the NANBYO field. 
 Examples of publicly accessible papers in English include: [1] Annual Meeting of the Japanese Society of Toxicology (2020)

• English: https://www.jstage.jst.go.jp/article/toxpt/47.1/0/47.1_W7-5/_article/-char/en
• DOI (Japanese): https://doi.org/10.14869/toxpt.47.1.0_W7-5
• Our three authors (Shun Emoto, Kunihiro Nishimura, and Yukiko Nishimura) contributed to this paper as ASrid members. [2] Orphanet Journal of Rare Diseases (2020)
• DOI: https://doi.org/10.1186/s13023-020-01550-1
• Our three authors (Shun Emoto, Kunihiro Nishimura, and Yukiko Nishimura) and affiliation (ASrid) are listed in the P4 poster abstract. [3] Rare Disease and Orphan Drugs Journal (2024)
• DOI: https://doi.org/10.20517/rdodj.2023.42
• Yukiko Nishimura is currently involved in the writing of this article as an ASrid member.

[ror-curator-bot]

Wikidata Name: Asrida Wikidata ID: Q108888823 Wikidata name match ratio: 91 Publication affiliation usage: ASrid: https://doi.org/10.20517/rdodj.2022.01, https://doi.org/10.1186/s13023-020-01550-1 | NPO ASrid: https://doi.org/10.1186/s13023-020-01550-1 Potential aliases: ASrid; NPO ASrid

[adambuttrick]

Rare disease research nonprofit in Japan. Funds and employs researchers. Solid affiliation usage. Should be added.

[ror-curator-bot]

Assigned ROR ID https://ror.org/0409p1440 in release v1.46.